AACC Creatine Kinase MB (CK-MB) standardization material used as manufacturer's working calibrator is unable to harmonize CK-MB results between two commercial immunoassays [7]

Clinical Chemistry

Volumn 50, Issue 9, 2004, Pages 1711-1712

  Panteghini, Mauro ^a   Pagani, Franca ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB;

ANTIBODY SPECIFICITY; BLOOD SAMPLING; CALIBRATION; CALIBRATOR; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYME STABILITY; HUMAN; INTERMETHOD COMPARISON; LETTER; NONHUMAN; REPRODUCIBILITY; STANDARD; STANDARDIZATION;

CALIBRATION; CREATINE KINASE; CREATINE KINASE, MB FORM; HUMANS; IMMUNOASSAY; ISOENZYMES; MYOCARDIAL INFARCTION; REFERENCE STANDARDS;

EID: 4344623361     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.036707     Document Type: Letter

References (13)

1. Panteghini M. Current concepts in standardization of cardiac marker immunoassays. Clin Chem Lab Med 2004;42:3-8.
2. Panteghini M. Standardization of cardiac markers. In: Wu AHB, ed. Cardiac markers, 2nd ed. Totowa, NJ: Humana Press, 2003:213-29.
3. Stenman UH. Immunoassay standardization: is it possible, who is responsible, who is capable? Clin Chem 2001;47:815-20.
4. Rej R, Drake P. The nature of calibrators in immunoassays: are they commutable with test samples? Must they be? Scand J Clin Lab Invest 1991;51(Suppl 205):47-54.
5. Sánchez M, Canalias F, Palencia T, Gella FJ. Creatine kinase 2 mass measurement: methods comparison and study of the matrix effect. Clin Chim Acta 1999;288:111-9.
6. Christenson RH, Vaidya H, Landt Y, Bauer RS, Green SF, Apple FA, et al. Standardization of creatine kinase-MB (CK-MB) mass assays: the use of recombinant CK-MB as a reference material. Clin Chem 1999;45:1414-23.
7. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Off J Eur Communities 1998(Dec 7);L331:1-37.
8. Walters L. Beckman Coulter Access creatine kinase MB assay [Letter]. Clin Chem 2004;50: 458.
9. Pagani F, Bonetti G, Stefini F, Giubbini R, Cuccia C, Panteghini M. Assessment of myocardial infarction size and left ventricular function using Access AccuTnl troponin I assay [Abstract]. Biochim Clin 2004;28:156.
10. National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples; approved guideline EP9-A. Wayne, PA: NCCLS, 1995.
11. Cattozzo G, Franzini C, Melzi d'Eril GV. Myoglobin and creatine kinase isoenzyme MB mass assays: intermethod behaviour of patient sera and commercially available control materials. Clin Chim Acta 2001;303:55-60.
12. Dominici R, Cabrini E, Cattozzo G, Ceriotti F, Grazioli V, Scapellato L, et al. Intermethod variation in serum carcinoembryonic antigen (CEA) measurement. Fresh serum pools and control materials compared. Clin Chem Lab Med 2002;40:167-73.
13. Sánchez M, Gella FJ, Profilis C, Ceriotti F, Cuso E, Fuentes-Arderiu X, et al. Certification of the mass concentration of creatine kinase isoenzyme 2 (CK-MB) in the reference material BCR 608. Clin Chem Lab Med 2001;39:858-65.